Two widely available medicines can safely improve brain health in those with early Alzheimer’s disease, a new study has found ...

A new breakthrough from researchers at Rice University could unlock the genetic components that determine several human ...

Lewy Body Dementia (LBD) is a brain disease that’s often misunderstood. It’s actually the second most common type of ...

Labcorp, one of the country’s largest providers of diagnostic medical testing services, announced today that it will offer ...

September 21, 2025, marked the 32nd World Alzheimer’s Day. Alzheimer’s disease (AD) is the primary cause of dementia. Often ...

Labcorp plans to offer Roche’s recently FDA-cleared blood test to assess early signs of Alzheimer’s disease and other causes ...

The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other ...

Johns Hopkins scientists found that neurons form tiny nanotube networks to transport toxins like amyloid-beta.

Plasma p-tau217 demonstrates strong accuracy in identifying Aβ pathology among cognitively unimpaired individuals.

Scientists have uncovered a toxic alliance between Aβ and fibrinogen that may explain how Alzheimer’s disease begins. The two ...

Doug Whitney, 76, carries a rare PSEN2 genetic mutation that causes early-onset Alzheimer's but shows no cognitive decline ...

A Southport cancer survivor and a Florida man fighting Alzheimer's are among inspiring athletes competing in Saturday's ...